Inferior Vena Cava Filters and Mortality: Is It the Underlying Process, the Patient, or the Device?

Eric A Secemsky^{1

2}, Brett J Carroll^{1

3}, Robert W Yeh^{1

2}

Affiliations

¹ Harvard Medical School, Boston, Massachusetts.
² Smith Center for Outcomes Research in Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
³ Division of Cardiovascular Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Free article

Comment

Eric A Secemsky et al. JAMA Netw Open. 2018.

Free article

. 2018 Jul 6;1(3):e180453.

doi: 10.1001/jamanetworkopen.2018.0453.

Eric A Secemsky^{1

2}, Brett J Carroll^{1

3}, Robert W Yeh^{1

2}

¹ Harvard Medical School, Boston, Massachusetts.
² Smith Center for Outcomes Research in Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
³ Division of Cardiovascular Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

No abstract available

Comment on

Association of Inferior Vena Cava Filter Placement for Venous Thromboembolic Disease and a Contraindication to Anticoagulation With 30-Day Mortality.
Turner TE, Saeed MJ, Novak E, Brown DL. Turner TE, et al. JAMA Netw Open. 2018 Jul 6;1(3):e180452. doi: 10.1001/jamanetworkopen.2018.0452. JAMA Netw Open. 2018. PMID: 30646021 Free PMC article.